drugset / Trial / NCT01651481
Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of Singulair (10 mg) and Xyzal (5 mg) in free combination and fixed-dose combination as HCP1102
Timeline
- Start
- 2012-07
- Primary completion
- 2012-09
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1102 | Unknown | 5 mg | — |
| Subject | HCP1102 | Unknown | 10 mg | — |
| Subject | Levocetirizine | Unknown | 5 mg | — |
| Subject | Montelukast | Other / unclassified | 10 mg | — |